🇺🇸 Non-selective NSAIDS in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 5

Most-reported reactions

1. Accident — 1 report (20%)
2. Joint Injury — 1 report (20%)
3. Lung Adenocarcinoma — 1 report (20%)
4. Metastases To Central Nervous System — 1 report (20%)
5. Plasmacytoma — 1 report (20%)

Source database →

Frequently asked questions

Is Non-selective NSAIDS approved in United States?

Non-selective NSAIDS does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Non-selective NSAIDS in United States?

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.